Stocks / NASDAQ / Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc.

Our Opinion

Soleno Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated on their press release that they exploit animals for clinical testing.

“These data are in agreement with results from a previous preclinical study and a Phase 1/2 clinical trial (NCT02034071) that showed treatment with DCCR significantly decreased fat mass and hyperphagia, and increased lean body mass in animal models and PWS patients.” Read the following article

Company Description

Company Website: